News

IRBLleida joins the European network of excellence EATRIS that gives access to technological facilities and leading projects in Europe

It is part of the biomarker work area for the prevention, diagnosis and prognostic evaluation of a disease

The Heroi sense capa web site devotes 5% of its sales to biomedical research on IRBLleida's COVID-19

The entrepreneur Berta López promotes this initiative

The IRBLleida reactivates research seminars and becomes online

They are carried out thanks to the virtual teaching platform of the University of Lleida

GO_HERO opens a call to offer researchers a training program on how to write successful European proposals

Successful candidates will attend a 4 session workshop to prepare Horizon 2020 and Horizon Europe proposals led by Dr Nikolaos Floratos.

The Instituto de Salud Carlos III funds two new research projects in Lleida on multiple sclerosis and COVID-19 and to identify potential drugs directed against a key protein for entry of the SARS-CoV2 virus

UdL, IRBLleida and HUAV initiate a research study to evaluate the efficacy of chloroquine treatment against COVID-19

Ignacio Lucas, from the Neurocognition, psychobiology of the personality and behavioral genetics group, defends his doctoral thesis online

Lleida study demonstrates the protective effect of a protein to reduce the progression of fibrosis of the kidneys

Two scientists from Lleida at “Científiques Catalanes 2.0” exhibition

IRBLleida joins the Portal de la Recerca de Catalunya (PRC) to promote the researchers projects

Health funds a Lleida research project to identify potential drugs targeted against a key protein for the entry of SARS-CoV2 virus

New campaingto raise funds for research against coronavirus at the Lleida Biomedical Research Institute (IRBLleida)